British Journal of Cancer - Table of Contents alert Volume 113 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 113, Issue 4 (569-692) Published online 11 August 2015 In this issue Minireviews Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The British Journal of Cancer presents four special Web Focuses in key areas of interest. Click on the links below to access each focus for free. Web Focus on Systemic Inflammation as a Prognostic Marker in Cancer  Web Focus on Melanoma, the Great Leap Forward Web Focus on New Drugs to Watch Web Focus on The Changing Landscape of Breast Cancer Prognostic Prediction   Minireviews Top MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients M Pichler and G A Calin Br J Cancer 2015 113: 569-573; advance online publication, July 9, 2015; 10.1038/bjc.2015.253 Abstract | Full Text Targeting LKB1 in cancer – exposing and exploiting vulnerabilities M Momcilovic and D B Shackelford Br J Cancer 2015 113: 574-584; advance online publication, July 21, 2015; 10.1038/bjc.2015.261 Abstract | Full Text Clinical Studies Top Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer Nathalie Quenel-Tueux, Marc Debled, Justine Rudewicz, Gaetan MacGrogan, Marina Pulido, Louis Mauriac, Florence Dalenc, Thomas Bachelot, Barbara Lortal, Christelle Breton-Callu, Nicolas Madranges, Christine Tunon de Lara, Marion Fournier, Hervé Bonnefoi, Hayssam Soueidan, Macha Nikolski, Audrey Gros, Catherine Daly, Henry Wood, Pamela Rabbitts and Richard Iggo Br J Cancer 2015 113: 585-594; advance online publication, July 14, 2015; 10.1038/bjc.2015.247 Abstract | Full Text The impact of positive peritoneal cytology on prognosis in patients with cervical cancer: a meta-analysis Sang-Hee Yoon, Soo-Nyung Kim, Seung-Hyuk Shim, Ji-Young Lee, Sun-Joo Lee, In-Kyeong Oh, Hyeon-Jeong Kim and Soon-Beom Kang Br J Cancer 2015 113: 595-602; advance online publication, July 30, 2015; 10.1038/bjc.2015.266 Abstract | Full Text Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer J Rees, C N Hurt, S Gollins, S Mukherjee, T Maughan, S J Falk, J Staffurth, R Ray, N Bashir, J I Geh, D Cunningham, R Roy, J Bridgewater, G Griffiths, L S Nixon, J M Blazeby and T Crosby Br J Cancer 2015 113: 603-610; advance online publication, July 23, 2015; 10.1038/bjc.2015.258 Abstract | Full Text Translational Therapeutics Top Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data Jayant K Rane, Antti Ylipää, Rachel Adamson, Vincent M Mann, Matthew S Simms, Anne T Collins, Tapio Visakorpi, Matti Nykter and Norman J Maitland Br J Cancer 2015 113: 611-615; advance online publication, July 23, 2015; 10.1038/bjc.2015.262 Abstract | Full Text Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma H Yu, R Liu, B Ma, X Li, H-y Yen, Y Zhou, V Krasnoperov, Z Xia, X Zhang, A M Bove, M Buscarini, D Parekh, I S Gill, Q Liao, M Tretiakova, D Quinn, J Zhao and P S Gill Br J Cancer 2015 113: 616-625; advance online publication, July 16, 2015; 10.1038/bjc.2015.237 Abstract | Full Text Molecular Diagnostics Top Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma Y Chang, H An, L Xu, Y Zhu, Y Yang, Z Lin and J Xu Br J Cancer 2015 113: 626-633; advance online publication, July 2, 2015; 10.1038/bjc.2015.241 Abstract | Full Text Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis C Blick, A Ramachandran, R McCormick, S Wigfield, D Cranston, J Catto and A L Harris Br J Cancer 2015 113: 634-644; advance online publication, July 21, 2015; 10.1038/bjc.2015.203 Abstract | Full Text TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature L E Podleska, K Funk, L Umutlu, F Grabellus, G Taeger and H de Groot Br J Cancer 2015 113: 645-652; advance online publication, July 14, 2015; 10.1038/bjc.2015.246 Abstract | Full Text Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers P Baruah, M Lee, P O G Wilson, T Odutoye, P Williamson, N Hyde, J C Kaski and I E Dumitriu Br J Cancer 2015 113: 653-659; advance online publication, July 14, 2015; 10.1038/bjc.2015.251 Abstract | Full Text MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways Sanjeev K Srivastava, Arun Bhardwaj, Sumit Arora, Nikhil Tyagi, Seema Singh, Joel Andrews, Steve McClellan, Bin Wang and Ajay P Singh Br J Cancer 2015 113: 660-668; advance online publication, August 6, 2015; 10.1038/bjc.2015.252 Abstract | Full Text Effects of growth arrest and DNA damage-inducible protein 34 (GADD34) on inflammation-induced colon cancer in mice Yuriko Tanaka, Sachiko Ito, Reina Oshino, Nana Chen, Naomi Nishio and Ken-ichi Isobe Br J Cancer 2015 113: 669-679; advance online publication, July 21, 2015; 10.1038/bjc.2015.263 Abstract | Full Text Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers A Harlé, J Salleron, G Perkins, C Pilati, H Blons, P Laurent-Puig and J L Merlin Br J Cancer 2015 113: 680-685; advance online publication, July 14, 2015; 10.1038/bjc.2015.250 Abstract | Full Text Genetics & Genomics Top Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation Manuela Pinheiro, Carla Pinto, Ana Peixoto, Isabel Veiga, Paula Lopes, Rui Henrique, Helena Baldaia, Fátima Carneiro, Raquel Seruca, Ian Tomlinson, Michal Kovac, Karl Heinimann and Manuel R Teixeira Br J Cancer 2015 113: 686-692; advance online publication, August 6, 2015; 10.1038/bjc.2015.281 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.